Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19387456rdf:typepubmed:Citationlld:pubmed
pubmed-article:19387456lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C0920317lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C0024143lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C1420799lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C0018591lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C2699638lld:lifeskim
pubmed-article:19387456lifeskim:mentionsumls-concept:C0205488lld:lifeskim
pubmed-article:19387456pubmed:issue5lld:pubmed
pubmed-article:19387456pubmed:dateCreated2009-7-22lld:pubmed
pubmed-article:19387456pubmed:abstractTextTNFAIP3 encodes the ubiquitin-modifying enzyme, A20, a key regulator of inflammatory signaling pathways. We previously reported association between TNFAIP3 variants and systemic lupus erythematosus (SLE). To further localize the risk variant(s), we performed a meta-analysis using genetic data available from two Caucasian case-control datasets (1453 total cases, 3381 total control subjects) and 713 SLE trio families. The best result was found at rs5029939 (P=1.67 x 10(-14), odds ratio=2.09, 95% confidence interval 1.68-2.60). We then imputed single nucleotide polymorphisms (SNPs) from the CEU Phase II HapMap using genotypes from 431 SLE cases and 2155 control subjects. Imputation identified 11 SNPs in addition to three observed SNPs, which together, defined a 109 kb SLE risk segment surrounding TNFAIP3. When evaluating whether the rs5029939 risk allele was associated with SLE clinical manifestations, we observed that heterozygous carriers of the TNFAIP3 risk allele at rs5029939 have a twofold increased risk of developing renal or hematologic manifestations compared to homozygous non-risk subjects. In summary, our study strengthens the genetic evidence that variants in the region of TNFAIP3 influence risk for SLE, particularly in patients with renal and hematologic manifestations, and narrows the risk effect to a 109 kb DNA segment that spans the TNFAIP3 gene.lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:languageenglld:pubmed
pubmed-article:19387456pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:citationSubsetIMlld:pubmed
pubmed-article:19387456pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19387456pubmed:statusMEDLINElld:pubmed
pubmed-article:19387456pubmed:monthJullld:pubmed
pubmed-article:19387456pubmed:issn1476-5470lld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:KellyJ AJAlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:JamesJ AJAlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:BatesJ SJSlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:HarleyJ BJBlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:LeonJ MJMlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:RodgersJJlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:NguyenTTlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:GilkesonG SGSlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:HumphreyM BMBlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:KaufmanK MKMlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:MoserK LKLlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:GaffneyP MPMlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:Gray-McGuireC...lld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:LessardC JCJlld:pubmed
pubmed-article:19387456pubmed:authorpubmed-author:BattiestL JLJlld:pubmed
pubmed-article:19387456pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19387456pubmed:volume10lld:pubmed
pubmed-article:19387456pubmed:ownerNLMlld:pubmed
pubmed-article:19387456pubmed:authorsCompleteYlld:pubmed
pubmed-article:19387456pubmed:pagination470-7lld:pubmed
pubmed-article:19387456pubmed:dateRevised2011-5-5lld:pubmed
pubmed-article:19387456pubmed:meshHeadingpubmed-meshheading:19387456...lld:pubmed
pubmed-article:19387456pubmed:meshHeadingpubmed-meshheading:19387456...lld:pubmed
pubmed-article:19387456pubmed:meshHeadingpubmed-meshheading:19387456...lld:pubmed
pubmed-article:19387456pubmed:meshHeadingpubmed-meshheading:19387456...lld:pubmed
pubmed-article:19387456pubmed:meshHeadingpubmed-meshheading:19387456...lld:pubmed
pubmed-article:19387456pubmed:meshHeadingpubmed-meshheading:19387456...lld:pubmed
pubmed-article:19387456pubmed:year2009lld:pubmed
pubmed-article:19387456pubmed:articleTitleMeta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations.lld:pubmed
pubmed-article:19387456pubmed:affiliationOklahoma Medical Research Foundation, Arthritis and Immunology Research Program, Oklahoma City, OK 73104, USA.lld:pubmed
pubmed-article:19387456pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19387456pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:19387456pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19387456pubmed:publicationTypeMeta-Analysislld:pubmed
pubmed-article:19387456pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed